- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/22 - Ribonucleases
Patent holdings for IPC class C12N 9/22
Total number of patents in this class: 12941
10-year publication summary
283
|
410
|
631
|
797
|
1015
|
1133
|
1243
|
1505
|
1790
|
1250
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20059 |
545 |
The Broad Institute, Inc. | 1837 |
510 |
Massachusetts Institute of Technology | 10102 |
461 |
President and Fellows of Harvard College | 5995 |
461 |
Sangamo Therapeutics, Inc. | 420 |
170 |
The General Hospital Corporation | 4759 |
162 |
The Board of Trustees of the Leland Stanford Junior University | 6451 |
154 |
Pairwise Plants Services, Inc. | 246 |
147 |
Cellectis | 407 |
143 |
CRISPR Therapeutics AG | 368 |
141 |
Arbor Biotechnologies Inc. | 168 |
141 |
Editas Medicine, Inc. | 254 |
138 |
Pioneer Hi-Bred International, Inc. | 6627 |
128 |
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 286 |
128 |
Beam Therapeutics Inc. | 242 |
120 |
Regeneron Pharmaceuticals, Inc. | 4323 |
114 |
Novozymes A/S | 3329 |
113 |
Duke University | 3087 |
113 |
Precision Biosciences, Inc. | 181 |
105 |
University of Massachusetts | 2235 |
102 |
Other owners | 8845 |